70380-50-6 Usage
Uses
Used in Pharmaceutical and Agrochemical Synthesis:
Ethyl N-(2,3-dichloro-6-nitrobenzyl)glycine is used as a key building block for the synthesis of various pharmaceutical and agrochemical compounds. Its unique structure and reactivity contribute to the development of new drugs and pesticides.
Used in Herbicide and Pest Control Agent Development:
In the Agrochemical Industry, Ethyl N-(2,3-dichloro-6-nitrobenzyl)glycine is used as an active ingredient in the development of herbicides and pest control agents. Its ability to inhibit the growth of certain plants and organisms makes it a valuable component in these applications.
Used in Medicinal Research for Neurological Disorders and Cancer:
Ethyl N-(2,3-dichloro-6-nitrobenzyl)glycine is used as a research compound in the field of medicinal chemistry for exploring its potential in treating neurological disorders and cancer. Its unique chemical properties may offer new avenues for therapeutic intervention in these areas.
Check Digit Verification of cas no
The CAS Registry Mumber 70380-50-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,3,8 and 0 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 70380-50:
(7*7)+(6*0)+(5*3)+(4*8)+(3*0)+(2*5)+(1*0)=106
106 % 10 = 6
So 70380-50-6 is a valid CAS Registry Number.
70380-50-6Relevant articles and documents
Process for the Manufacture of Anagrelide Hydrochloride Monohydrate
-
Page/Page column 2; 3, (2010/12/29)
The present invention relates to a process for preparation of Anagrelide Hydrochloride Monohydrate.
PROCESS FOR THE PREPARATION OF ETHYL-N-(2, 3-DICHLORO-6-NITROBENZYL) GLYCINE HYDROCHLORIDE
-
Page/Page column 13, (2008/12/08)
The invention relates to a process for the preparation of anagrelide, and for the preparation of intermediates for use in preparing anagrelide. The invention also relates to the inte?nediates per se, in particular compounds of formula (V) where R constitutes a suitable leaving group, which may not be hydrogen. The R group may be is selected from: (i) -SiR1 3, (ii) -CH2Ar, (iii) -COOR2, and (iv) sulfonates such as -SO2R3.
USE OF 2-AMINO-2H-QUINAZOLINE DERIVATIVES FOR PRODUCING THERAPEUTIC AGENTS
-
Page/Page column 9-10, (2010/02/07)
The invention relates to the use of 2-amino-2H-quinazoline derivatives of general chemical formula (I), wherein R1 represents an alkyl group having 1 - 5 carbon atoms and R2, R3, R4 and R5 independently represent a chlorine or hydrogen atom, in addition to the pharmaceutically compatible salts thereof for producing therapeutic agents for treating myeloproliferative diseases, high blood pressure and bronchodilation.